Table 10 Relation between the epigenetic marker (Linc-ITGB1) and the clinicopathological parameters (n = 80)
N | Epigenetic marker (Linc-ITGB1) | Test of sig | p | |
|---|---|---|---|---|
Median (IQR) | ||||
Age (years) | ||||
< 50 | 34 | 6.0 (1.32–18.90) | U = 673.0 | 0.289 |
≥ 50 | 46 | 2.81 (0.82–10.41) | ||
Menstrual status | ||||
Premenopausal | 34 | 6.0 (1.32–18.90) | U = 673.0 | 0.289 |
Postmenopausal | 46 | 2.81 (0.82–10.41) | ||
Clinical presentation | ||||
Asymptomatic | 7 | 4.96 (3.81–10.55) | U = 233.0 | 0.702 |
Symptomatic | 73 | 3.66 (0.93–10.85) | ||
Parity | ||||
Nullipara | 18 | 2.82 (0.93–8.0) | U = 517.0 | 0.637 |
Multipara | 62 | 4.88 (1.07–15.56) | ||
Histological type | ||||
IDC | 75 | 4.89 (1.13–11.05) | U = 99.0 | 0.750 |
ILC | 3 | 2.75 (1.41–12.61) | ||
DCIS | 1# | – | ||
Mucinous | 1# | – | ||
Grading of IDC | ||||
II | 19 | 6.68 (0.87–13.17) | U = 513.0 | 0.817 |
III | 55 | 4.33 (1.26–11.04) | ||
Immune histochemical markers | ||||
Luminal | 68 | 4.88 (0.88–16.42) | U = 374.50 | 0.652 |
Non-luminal | 12 | 3.10 (1.38–8.49) | ||